Lv2
175 积分 2022-03-29 加入
Atezolizumab and bevacizumab combination compared with sorafenib as the first‐line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost‐effectiveness analysis in China and the United states
2年前
已完结
Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children
2年前
已完结
Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma
2年前
已完结
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma
2年前
已完结
Preventing the onset of major depressive disorder: A meta-analytic review of psychological interventions
2年前
已完结
A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
2年前
已完结
Incidence trends of major depressive disorder in China: an age-period-cohort modeling study
2年前
已完结
Cost-effectiveness of omalizumab for the treatment of inadequately controlled severe allergic asthma in Chinese children
2年前
已完结
Budesonide/Formoterol Maintenance Plus Reliever Therapy
2年前
已完结
As-Needed Budesonide–Formoterol versus Maintenance Budesonide in Mild Asthma
2年前
已完结
皖公网安备34019202002308
